An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method.
about
Production of adenovirus vectors and their use as a delivery system for influenza vaccines.Adenovirus-based libraries: efficient generation of recombinant adenoviruses by positive selection with the adenovirus protease.Modulation of TNFalpha, a determinant of acute toxicity associated with systemic delivery of first-generation and helper-dependent adenoviral vectors.Interleukin-15 and its receptor augment dendritic cell vaccination against the neu oncogene through the induction of antibodies partially independent of CD4 help.Vesicular stomatitis virus as a novel cancer vaccine vector to prime antitumor immunity amenable to rapid boosting with adenovirus.Immunization with a bivalent adenovirus-vectored tuberculosis vaccine provides markedly improved protection over its monovalent counterpart against pulmonary tuberculosisTWEAK induces liver progenitor cell proliferationAngiotensin-converting enzyme 2 attenuates atherosclerotic lesions by targeting vascular cellsConstruction and immunogenicity of recombinant adenovirus vaccines expressing the HMW1, HMW2, or Hia adhesion protein of nontypeable Haemophilus influenzaeTransfer of the IL-37b gene elicits anti-tumor responses in mice bearing 4T1 breast cancer.Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes.Nogo-B protects mice against lipopolysaccharide-induced acute lung injuryCombined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patientsGene transfer into cardiac myocytes.T-cell immunity generated by recombinant adenovirus vaccines.Regulated expression of adenoviral vectors-based gene therapies: therapeutic expression of toxins and immune-modulators.The novel replication-defective vaccinia virus (Tiantan strain)-based hepatitis C virus vaccine induces robust immunity in macaquesPersistence of transgene expression influences CD8+ T-cell expansion and maintenance following immunization with recombinant adenovirus.Vaccination with tumor cells expressing IL-15 and IL-15Rα inhibits murine breast and prostate cancer.Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor.Optimizing vaccine-induced CD8(+) T-cell immunity: focus on recombinant adenovirus vectors.Enhancing Immune Responses to Cancer Vaccines Using Multi-Site Injections.A simplified in vitro ligation approach to clone an E1B55k-deleted double-targeted conditionally-replicative adenovirus.High-dose chemotherapy augments the efficacy of recombinant adenovirus vaccines and improves the therapeutic outcome.Detailed analysis of the CD8+ T-cell response following adenovirus vaccination.High throughput creation of recombinant adenovirus vectors by direct cloning, green-white selection and I-Sce I-mediated rescue of circular adenovirus plasmids in 293 cells.Effect of adenovirus-mediated RNA interference of IL-1β expression on spinal cord injury in rats.Transposon-assisted cloning and traceless mutagenesis of adenoviruses: Development of a novel vector based on species D.HER3 targeting of adenovirus by fiber modification increases infection of breast cancer cells in vitro, but not following intratumoral injection in mice.Enabling topical immunization via microporation: a novel method for pain-free and needle-free delivery of adenovirus-based vaccines.Adenoviral-transduced dendritic cells are susceptible to suppression by T regulatory cells and promote interleukin 17 production.Angiotensin-converting enzyme-2 overexpression attenuates inflammation in rat model of chronic obstructive pulmonary disease.Disruption of MAP kinase activation and nuclear factor binding to the IL-12 p40 promoter in HIV-infected myeloid cells.
P2860
Q30226988-CEFABEA9-4EEF-4445-8FF8-F422321155A5Q30846322-02449F5E-6FE5-4D4E-819B-E21D719BA39CQ33371239-21DE0975-C7A0-49D7-BC3E-7AA08362D700Q33638464-70B73F58-C555-48CF-847A-2956B01C431BQ33713083-72C5AF1E-C609-43D9-8AFA-4046F38DBA90Q33713700-52555FAA-EAFC-4235-A299-0243AE830644Q33919951-6E683D8C-0941-4133-B880-09F90D2172A3Q34115516-199C209D-0449-4CE9-A230-52887C560297Q34189901-F6D1B0EE-4556-4832-8FBE-6679CD542D01Q35289513-DD73CAD4-BDA4-4C85-A19D-759A39D9DF82Q35576891-31DD9DF5-A33A-488D-BDFF-881A90C5C249Q35852315-27AFC99F-5176-4F9E-AF55-DC4D81C41215Q36057487-1E5A08E9-9579-41A6-B53B-39261D70ABF9Q36543945-E56ACC75-5650-4140-8FFC-0BE6FF8D2CAAQ36837129-E081EF3B-DC99-4AB4-A880-09C2B8537104Q37079181-8A9255EE-55D6-4EA1-92B9-3F5EF41B939CQ37181386-BCAFB15B-4594-494F-87D0-9D67CA843641Q37452136-BB04D169-AF76-49F7-A97F-403F4AA83A70Q37685855-6155C173-1D93-4574-ACCC-94F35977B350Q37690444-CF378A79-BB28-4631-8F4E-8B15DD22212EQ37932525-6F655058-78B7-4BD6-85A9-8053F8AC1A9BQ38641485-431C6456-36AD-4D9F-B5E6-C1F3A74F6987Q39886435-28C418EB-FA5A-4229-8E93-F618BAF4F038Q39920459-4682019B-2350-45EC-BFF8-374DC8834112Q40344509-8D938567-1154-4B3F-9EF7-ACC35659D36FQ40632778-F2139BF7-F30F-4B20-96F9-A4D1B9E69A8FQ40895091-6970A662-28AD-4224-896F-BD6FD45AE48BQ41900379-0ED81C14-2654-4C4A-82A7-02FD8EB46878Q42288961-E0A28855-5883-4BB1-A6E4-BCAC718EE2ABQ44305187-E6A85B09-319B-4205-B403-025A3FD5624BQ44626008-30066269-F43C-4323-A30E-AE45B6556B30Q46947045-434B7BBE-924A-4901-95D9-550B3ADACDA4Q52559089-85EF352B-EEFD-4AF0-AC66-C89C1A974DA9
P2860
An enhanced system for construction of adenoviral vectors by the two-plasmid rescue method.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
An enhanced system for constru ...... the two-plasmid rescue method.
@en
type
label
An enhanced system for constru ...... the two-plasmid rescue method.
@en
prefLabel
An enhanced system for constru ...... the two-plasmid rescue method.
@en
P2093
P1433
P1476
An enhanced system for constru ...... the two-plasmid rescue method.
@en
P2093
P304
P356
10.1089/10430340050015590
P577
2000-03-01T00:00:00Z